Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
- 2 December 2021
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 62 (Supplement) , 48S-59S
Abstract
Interest in performing dosimetry for clinical radiopharmaceutical therapy procedures has grown in recent years. Several approved therapies include dosimetry in the Food and Drug Administration–approved label instructions, and other therapies are best used under a patient-tailored paradigm. This paper, which is a product of the Society of Nuclear Medicine and Molecular Imaging Dosimetry Task Force, presents motivations and general workflows for radiopharmaceutical therapy dosimetry, as well as existing strategies for obtaining reimbursement for clinical activities related to dosimetry. Several specific patient examples are provided, including suggested codes for reimbursement. In addition to current reimbursement approaches, key dosimetry services that are not supported under the current coding structure are presented and suggested as areas of focus in the coming years.Keywords
This publication has 40 references indexed in Scilit:
- MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide TherapyJournal of Nuclear Medicine, 2012
- Radioembolization for the Treatment of Liver TumorsAmerican Journal of Clinical Oncology, 2012
- Thyroid and hepatic function after high‐dose 131I‐metaiodobenzylguanidine (131I‐MIBG) therapy for neuroblastomaPediatric Blood & Cancer, 2010
- Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinomaEndocrine-Related Cancer, 2009
- A dose-effect correlation for radioiodine ablation in differentiated thyroid cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of NomenclatureJournal of Nuclear Medicine, 2009
- MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide TherapyJournal of Nuclear Medicine, 2008
- Optimization of Equipment and Methodology for Whole Body Activity Retention Measurements in Children Undergoing Targeted Radionuclide TherapyCancer Biotherapy and Radiopharmaceuticals, 2007
- Relation between Effective Radiation Dose and Outcome of Radioiodine Therapy for Thyroid CancerNew England Journal of Medicine, 1983
- The X-raysScience, 1896